Avaleht › Difuusne suure B-raku lümfoom › Wisconsin › Milwaukee
Difuusne suure B-raku lümfoom kliinilised uuringud linnas Milwaukee, WI
16 uuringut haiguse Difuusne suure B-raku lümfoom jaoks otsivad osalejaid linnas Milwaukee ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
VärbamineVaatlusuuring
- Children's Hospital of Wisconsin, Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
VärbamineFaas 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi kaugusel
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi kaugusel
- ja veel 3
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
VärbamineFaas 2
- Medical College of Wisconsin ( Site 0103), Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
VärbamineFaas 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
VärbamineFaas 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
VärbamineFaas 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
VärbamineFaas 1/2
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
VärbamineFaas 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
VärbamineFaas 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
VärbamineVaatlusuuring
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
VärbamineFaas 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
VärbamineFaas 1
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
VärbamineFaas 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
VärbamineFaas 2
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi kaugusel
Long-term Follow-up Study of Patients Receiving CAR-T Cells
VärbamineVaatlusuuring
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
VärbamineFaas 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- ja veel 4
Difuusne suure B-raku lümfoom uuringud teistes linnades
- New York City, NY21 uuringut
- Baldwin Park, CA19 uuringut
- Chicago, IL18 uuringut
- Houston, TX17 uuringut
- Los Angeles, CA17 uuringut
- Boston, MA16 uuringut
- Nashville, TN15 uuringut
- Portland, OR15 uuringut
- Philadelphia, PA15 uuringut
- Durham, NC14 uuringut
- Dallas, TX13 uuringut
- Seattle, WA12 uuringut
Muud uuringud linnas Milwaukee
- Rinnavähk23 uuringut
- Mitteväikerakuline kopsuvähk22 uuringut
- Vähk (kõik liigid)22 uuringut
- Kopsuvähk21 uuringut
- Müeloom21 uuringut
- Eesnäärmevähk20 uuringut
- Follikulaarne lümfoom19 uuringut
- Pankreasevähk18 uuringut
- Mittet Hodgkini lümfoom18 uuringut
- Munasarjavähk17 uuringut
- Äge müeloidne leukeemia17 uuringut
- Burkitti lümfoom16 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.